These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Comparison of the effects of citalopram and escitalopram on 5-Ht-mediated neuroendocrine responses. Nadeem HS; Attenburrow MJ; Cowen PJ Neuropsychopharmacology; 2004 Sep; 29(9):1699-703. PubMed ID: 15127082 [TBL] [Abstract][Full Text] [Related]
7. Blunted TSH response to TRH and seizure duration in ECT. Papakostas YG; Markianos M; Pehlivanidis A; Zervas IM; Papadimitriou GN; Stefanis C Acta Psychiatr Scand; 1999 Jan; 99(1):68-72. PubMed ID: 10066009 [TBL] [Abstract][Full Text] [Related]
8. Serotonergic and dopaminergic neuroendocrine responses of male depressive patients before and after a therapeutic ECT course. Markianos M; Hatzimanolis J; Lykouras L Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):172-6. PubMed ID: 12242578 [TBL] [Abstract][Full Text] [Related]
10. Effects of ECT on pituitary hormone release: relationship to seizure, clinical variables and outcome. Deakin JF; Ferrier IN; Crow TJ; Johnstone EC; Lawler P Br J Psychiatry; 1983 Dec; 143():618-24. PubMed ID: 6661605 [TBL] [Abstract][Full Text] [Related]
11. Oral application of citalopram (20 mg) and its usefulness for neuroendocrine challenge tests. Henning J; Netter P Int J Neuropsychopharmacol; 2002 Mar; 5(1):67-71. PubMed ID: 14609009 [TBL] [Abstract][Full Text] [Related]
12. Impact of the selective serotonin reuptake inhibitor citalopram on insulin sensitivity, leptin and basal cortisol secretion in depressed and non-depressed euglycemic women of reproductive age. Kauffman RP; Castracane VD; White DL; Baldock SD; Owens R Gynecol Endocrinol; 2005 Sep; 21(3):129-37. PubMed ID: 16335904 [TBL] [Abstract][Full Text] [Related]
13. Effect of ECT on the neuroendocrine response to apomorphine in severely depressed patients. Christie JE; Whalley LJ; Brown NS; Dick H Br J Psychiatry; 1982 Mar; 140():268-73. PubMed ID: 6807386 [TBL] [Abstract][Full Text] [Related]
14. L-5-Hydroxytryptophan augments the neuroendocrine response to a SSRI. Lowe SL; Yeo KP; Teng L; Soon DK; Pan A; Wise SD; Peck RW Psychoneuroendocrinology; 2006 May; 31(4):473-84. PubMed ID: 16378695 [TBL] [Abstract][Full Text] [Related]
15. Thyrotropin-releasing hormone administration does not affect seizure threshold during electroconvulsive therapy. Zervas IM; Papakostas YG; Theodoropoulou MA; Dimitrakopoulos C; Vaidakis N; Daras M J ECT; 2003 Sep; 19(3):136-8. PubMed ID: 12972982 [TBL] [Abstract][Full Text] [Related]
16. Thyrotropin and prolactin responses to ECT in schizophrenia and depression. Papakostas Y; Markianos M; Papadimitriou G; Lykouras L; Stefanis C Psychiatry Res; 1991 Apr; 37(1):5-10. PubMed ID: 1862162 [TBL] [Abstract][Full Text] [Related]
17. The effect of acute and repeated electroconvulsive treatment on plasma beta-endorphin, growth hormone, prolactin and cortisol secretion in depressed patients. Weizman A; Gil-Ad I; Grupper D; Tyano S; Laron Z Psychopharmacology (Berl); 1987; 93(1):122-6. PubMed ID: 2957720 [TBL] [Abstract][Full Text] [Related]
18. The effects of an acute serotonergic challenge on brain-gut responses in irritable bowel syndrome patients and controls. Kilkens TO; Honig A; Fekkes D; Brummer RJ Aliment Pharmacol Ther; 2005 Nov; 22(9):865-74. PubMed ID: 16225497 [TBL] [Abstract][Full Text] [Related]